The DOI matches its Crossref record; 169 of the 169 references it cites were found in a registry or an index.
Curcumin mediates anticancer effects by modulating multiple cell signaling pathways
Abstract
Curcumin, a component of a spice native to India, was first isolated in 1815 by Vogel and Pelletier from the rhizomes of Curcuma longa (turmeric) and, subsequently, the chemical structure of curcumin as diferuloylmethane was reported by Milobedzka et al. [(1910) 43., 2163-2170]. Since then, this polyphenol has been shown to exhibit antioxidant, anti-inflammatory, anticancer, antiviral, antibacterial, and antifungal activities. The current review primarily focuses on the anticancer potential of curcumin through the modulation of multiple cell signaling pathways. Curcumin modulates diverse transcription factors, inflammatory cytokines, enzymes, kinases, growth factors, receptors, and various other proteins with an affinity ranging from the pM to the mM range. Furthermore, curcumin effectively regulates tumor cell growth via modulation of numerous cell signaling pathways and potentiates the effect of chemotherapeutic agents and radiation against cancer. Curcumin can interact with most of the targets that are modulated by FDA-approved drugs for cancer therapy. The focus of this review is to discuss the molecular basis for the anticancer activities of curcumin based on preclinical and clinical findings.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
Ali, S., Ahmad, A., Banerjee, S., Padhye, S., Dominiak, K., Schaffert, J. M., Wang, Z., Philip, P. A., & Sarkar, F. H. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-4598 · Cited by 424
RetractedGuan, F., Ding, Y., Zhang, Y., Zhou, Y., Li, M., & Wang, C. (2016) · PLoS ONE · doi:10.1371/journal.pone.0146553 · Cited by 139
RetractedHallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
Wang, G. L., Jiang, B. H., Rue, E. A., & Semenza, G. L. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.12.5510 · Cited by 6,212
Bioavailability of curcumin: Problems and promises
Anand, P., Kunnumakkara, A. B., Newman, R. A., & Aggarwal, B. B. (2007) · Molecular Pharmaceutics · doi:10.1021/mp700113r · Cited by 5,543
The Wnt Signaling Pathway in Development and Disease
Logan, C. Y., & Nusse, R. (2004) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.20.010403.113126 · Cited by 5,325
AP-1 as a regulator of cell life and death
Shaulian, E., & Karin, M. (2002) · Nature Cell Biology · doi:10.1038/ncb0502-e131 · Cited by 2,961
Karin, M., Liu, Z.-G., & Zandi, E. (1997) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(97)80068-3 · Cited by 2,893
Anticancer potential of curcumin: preclinical and clinical studies.
Aggarwal, B. B., Kumar, A. J., & Bharti, A. C. (2003) · PubMed · Cited by 2,550
Self-citationTherapeutic Roles of Curcumin: Lessons Learned from Clinical Trials
Gupta, S. C., Patchva, S., & Aggarwal, B. B. (2013) · The AAPS Journal · doi:10.1208/s12248-012-9432-8 · Cited by 2,110
Self-citationInducibility of κ immunoglobulin enhancer-binding protein NF-κB by a posttranslational mechanism
Sen, R., & Baltimore, D. (1986) · Cell · doi:10.1016/0092-8674(86)90807-x · Cited by 1,993
Curcumin: From ancient medicine to current clinical trials
Hatcher, H., Planalp, R., Cho, J., Torti, F. M., & Torti, S. V. (2008) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-008-7452-4 · Cited by 1,843
The EGFR family and its ligands in human cancer
Yarden, Y. (2001) · European Journal of Cancer · doi:10.1016/s0959-8049(01)00230-1 · Cited by 1,587
Activation of Transcription Factor NF-κB Is Suppressed by Curcumin (Diferuloylmethane)
Singh, S., & Aggarwal, B. B. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.42.24995 · Cited by 1,386
Self-citationPhase II Trial of Curcumin in Patients with Advanced Pancreatic Cancer
Dhillon, N., Aggarwal, B. B., Newman, R. A., Wolff, R. A., Kunnumakkara, A. B., Abbruzzese, J. L., Ng, C. S., Badmaev, V., & Kurzrock, R. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-0024 · Cited by 1,331
Self-citationPhase I Clinical Trial of Oral Curcumin
Sharma, R. A., Euden, S. A., Platton, S. L., Cooke, D. N., Shafayat, A., Hewitt, H. R., Marczylo, T. H., Morgan, B., Hemingway, D., Plummer, S. M., et al. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0744 · Cited by 1,257
Curcumin and cancer: An “old-age” disease with an “age-old” solution
Anand, P., Sundaram, C., Jhurani, S., Kunnumakkara, A. B., & Aggarwal, B. B. (2008) · Cancer Letters · doi:10.1016/j.canlet.2008.03.025 · Cited by 1,132
Self-citationHypoxia-inducible factor 1: master regulator of O2 homeostasis
Semenza, G. L. (1998) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(98)80016-6 · Cited by 1,092
Prasad, S., Tyagi, A. K., & Aggarwal, B. B. (2014) · Cancer Research and Treatment · doi:10.4143/crt.2014.46.1.2 · Cited by 1,057
Self-citationLong non-coding RNAs and cancer: a new frontier of translational research?
Spizzo, R., Almeida, M. I., Colombatti, A., & Calin, G. A. (2012) · Oncogene · doi:10.1038/onc.2011.621 · Cited by 1,004
Curcumin, a component of golden spice: From bedside to bench and back
Prasad, S., Gupta, S. C., Tyagi, A. K., & Aggarwal, B. B. (2014) · Biotechnology Advances · doi:10.1016/j.biotechadv.2014.04.004 · Cited by 858
Self-citationInhibiting NF-κB activation by small molecules as a therapeutic strategy
Gupta, S. C., Sundaram, C., Reuter, S., & Aggarwal, B. B. (2010) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2010.05.004 · Cited by 762
Self-citationAberrant nuclear factor-kappaB/Rel expression and the pathogenesis of breast cancer.
Sovak, M. A., Bellas, R. E., Kim, D. W., Zanieski, G. J., Rogers, A. E., Traish, A. M., & Sonenshein, G. E. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119848 · Cited by 720
Li, L., Braiteh, F. S., & Kurzrock, R. (2005) · Cancer · doi:10.1002/cncr.21300 · Cited by 644
Comprehensive Genomic Characterization of Long Non-coding RNAs across Human Cancers
Yan, X., Hu, Z., Feng, Y., Hu, X., Yuan, J., Zhao, S. D., Zhang, Y., Yang, L., Shan, W., He, Q., et al. (2015) · Cancer Cell · doi:10.1016/j.ccell.2015.09.006 · Cited by 643
Oral bioavailability of curcumin: problems and advancements
Liu, W., Zhai, Y., Heng, X., Che, F. Y., Chen, W., Sun, D., & Zhai, G. (2016) · Journal of Drug Targeting · doi:10.3109/1061186x.2016.1157883 · Cited by 566
Bharti, A. C., Donato, N., & Aggarwal, B. B. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.7.3863 · Cited by 508
Self-citationPhase IIa Clinical Trial of Curcumin for the Prevention of Colorectal Neoplasia
Carroll, R. E., Benya, R. V., Turgeon, D. K., Vareed, S., Neuman, M., Rodriguez, L., Kakarala, M., Carpenter, P. M., McLaren, C., Meyskens, F. L., et al. (2011) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-10-0098 · Cited by 503
Garcea, G., Berry, D. P., Jones, D. J. L., Singh, R., Dennison, A. R., Farmer, P. B., Sharma, R. A., Steward, W. P., & Gescher, A. J. (2005) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.120.14.1 · Cited by 494
Lin, Y. G., Kunnumakkara, A. B., Nair, A., Merritt, W. M., Han, L. Y., Armaiz-Pena, G. N., Kamat, A. A., Spannuth, W. A., Gershenson, D. M., Lutgendorf, S. K., et al. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-3072 · Cited by 440
Self-citationSun, M., Estrov, Z., Ji, Y., Coombes, K. R., Harris, D. H., & Kurzrock, R. (2008) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-07-2272 · Cited by 412
Bayet-Robert, M., Kwiatowski, F., Leheurteur, M., Gachon, F., Planchat, E., Abrial, C., Mouret-Reynier, M.-A., Durando, X., Barthomeuf, C., & Chollet, P. (2010) · Cancer Biology & Therapy · doi:10.4161/cbt.9.1.10392 · Cited by 399
Kanai, M., Yoshimura, K., Asada, M., Imaizumi, A., Suzuki, C., Matsumoto, S., Nishimura, T., Mori, Y., Masui, T., Kawaguchi, Y., et al. (2011) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-010-1470-2 · Cited by 399
Self-citationAGGARWAL, B. B., SETHI, G., AHN, K. S., SANDUR, S. K., PANDEY, M. K., KUNNUMAKKARA, A. B., SUNG, B., & ICHIKAWA, H. (2006) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1378.063 · Cited by 398
Self-citationCurcumin, a component of turmeric: From farm to pharmacy
Gupta, S. C., Kismali, G., & Aggarwal, B. B. (2013) · BioFactors · doi:10.1002/biof.1079 · Cited by 396
Self-citationJaiswal, A. S., Marlow, B. P., Gupta, N., & Narayan, S. (2002) · Oncogene · doi:10.1038/sj.onc.1205947 · Cited by 363
NF-κB–mediated Pax7 dysregulation in the muscle microenvironment promotes cancer cachexia
He, W. A., Berardi, E., Cardillo, V. M., Acharyya, S., Aulino, P., Thomas-Ahner, J., Wang, J., Bloomston, M., Muscarella, P., Nau, P., et al. (2013) · Journal of Clinical Investigation · doi:10.1172/jci68523 · Cited by 357
Baron, V, Adamson, E. D., Calogero, A., Ragona, G., & Mercola, D. (2006) · Cancer Gene Therapy · doi:10.1038/sj.cgt.7700896 · Cited by 346
Curcumin regulates miR-21 expression and inhibits invasion and metastasis in colorectal cancer
Mudduluru, G., George-William, J. N., Muppala, S., Asangani, I. A., Kumarswamy, R., Nelson, L. D., & Allgayer, H. (2011) · Bioscience Reports · doi:10.1042/bsr20100065 · Cited by 332
Curcumin exerts multiple suppressive effects on human breast carcinoma cells
Shao, Z., Shen, Z., Liu, C., Sartippour, M. R., Go, V. L., Heber, D., & Nguyen, M. (2002) · International Journal of Cancer · doi:10.1002/ijc.10183 · Cited by 313
Chemosensitization of tumors by resveratrol
Gupta, S. C., Kannappan, R., Reuter, S., Kim, J. H., & Aggarwal, B. B. (2011) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2010.05852.x · Cited by 305
Self-citationTargeting NRF2 signaling for cancer chemoprevention
Kwak, M.-K., & Kensler, T. W. (2010) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2009.08.028 · Cited by 305
Chen, A., Xu, J., & Johnson, A. C. (2006) · Oncogene · doi:10.1038/sj.onc.1209019 · Cited by 301
Turmeric and Curcumin as Topical Agents in Cancer Therapy
Kuttan, R., Sudheeran, P. C., & Josph, C. D. (1987) · Tumori Journal · doi:10.1177/030089168707300105 · Cited by 293
Anti-cancer activity of curcumin loaded nanoparticles in prostate cancer
Yallapu, M. M., Khan, S., Maher, D. M., Ebeling, M. C., Sundram, V., Chauhan, N., Ganju, A., Balakrishna, S., Gupta, B. K., Zafar, N., et al. (2014) · Biomaterials · doi:10.1016/j.biomaterials.2014.06.040 · Cited by 290
Curcumin and Gemcitabine in Patients With Advanced Pancreatic Cancer
Epelbaum, R., Schaffer, M., Vizel, B., Badmaev, V., & Bar-Sela, G. (2010) · Nutrition and Cancer · doi:10.1080/01635581.2010.513802 · Cited by 282
Upregulation of p53 Expression in Patients with Colorectal Cancer by Administration of Curcumin
He, Z.-Y., Shi, C.-B., Wen, H., Li, F.-L., Wang, B.-L., & Wang, J. (2011) · Cancer Investigation · doi:10.3109/07357907.2010.550592 · Cited by 274
Molecular mechanisms of curcumin action: Signal transduction
Shehzad, A., & Lee, Y. S. (2013) · BioFactors · doi:10.1002/biof.1065 · Cited by 248
Khor, T. O., Huang, Y., Wu, T.-Y., Shu, L., Lee, J., & Kong, A.-N. T. (2011) · Biochemical Pharmacology · doi:10.1016/j.bcp.2011.07.065 · Cited by 245
Philip, S., & Kundu, G. C. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m207309200 · Cited by 240
Curcumin Induces Cell Death in Esophageal Cancer Cells through Modulating Notch Signaling
Subramaniam, D., Ponnurangam, S., Ramamoorthy, P., Standing, D., Battafarano, R. J., Anant, S., & Sharma, P. (2012) · PLoS ONE · doi:10.1371/journal.pone.0030590 · Cited by 233
Multi‐targeted therapy by curcumin: how spicy is it?
Goel, A., Jhurani, S., & Aggarwal, B. B. (2008) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.200700354 · Cited by 228
Self-citationShehzad, A., Lee, J., & Lee, Y. S. (2013) · BioFactors · doi:10.1002/biof.1068 · Cited by 224
Choi, H., Chun, Y.-S., Kim, S.-W., Kim, M.-S., & Park, J.-W. (2006) · Molecular Pharmacology · doi:10.1124/mol.106.025817 · Cited by 219
JIN, H., QIAO, F., WANG, Y., XU, Y., & SHANG, Y. (2015) · Oncology Reports · doi:10.3892/or.2015.4258 · Cited by 210
Han, S.-S., Chung, S.-T., Robertson, D. A., Ranjan, D., & Bondada, S. (1999) · Clinical Immunology · doi:10.1006/clim.1999.4769 · Cited by 207
Panahi, Y., Saadat, A., Beiraghdar, F., & Sahebkar, A. (2014) · Phytotherapy Research · doi:10.1002/ptr.5149 · Cited by 204
Curcumin Synergizes With Resveratrol to Inhibit Colon Cancer
Majumdar, A. P. N., Banerjee, S., Nautiyal, J., Patel, B. B., Patel, V., Du, J., Yu, Y., Elliott, A. A., Levi, E., & Sarkar, F. H. (2009) · Nutrition and Cancer · doi:10.1080/01635580902752262 · Cited by 201
Kunnumakkara, A. B., Diagaradjane, P., Anand, P., Kuzhuvelil, H. B., Deorukhkar, A., Gelovani, J., Guha, S., Krishnan, S., & Aggarwal, B. B. (2009) · International Journal of Cancer · doi:10.1002/ijc.24593 · Cited by 199
Self-citationKanai, M., Otsuka, Y., Otsuka, K., Sato, M., Nishimura, T., Mori, Y., Kawaguchi, M., Hatano, E., Kodama, Y., Matsumoto, S., et al. (2013) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-013-2151-8 · Cited by 198
Chen, Y., Shu, W., Chen, W., Wu, Q., Liu, H., & Cui, G. (2007) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/j.1742-7843.2007.00142.x · Cited by 187
Curcumin inhibits hypoxia-induced angiogenesis via down-regulation of HIF-1
Bae, M.-K., Kim, S.-H., Jeong, J.-W., Lee, Y., Kim, H.-S., Kim, S.-R., Yun, I., Bae, S.-K., & Kim, K.-W. (2006) · Oncology Reports · doi:10.3892/or.15.6.1557 · Cited by 186
Ide, H., Tokiwa, S., Sakamaki, K., Nishio, K., Isotani, S., Muto, S., Hama, T., Masuda, H., & Horie, S. (2010) · The Prostate · doi:10.1002/pros.21147 · Cited by 181
Implications of cancer stem cell theory for cancer chemoprevention by natural dietary compounds
Li, Y., Wicha, M. S., Schwartz, S. J., & Sun, D. (2011) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2010.11.001 · Cited by 179
Tahira, A. C., Kubrusly, M. S., Faria, M. F., Dazzani, B., Fonseca, R. S., Maracaja-Coutinho, V., Verjovski-Almeida, S., Machado, M. C., & Reis, E. M. (2011) · Molecular Cancer · doi:10.1186/1476-4598-10-141 · Cited by 178
MicroRNA Processing and Human Cancer
Ohtsuka, M., Ling, H., Doki, Y., Mori, M., & Calin, G. (2015) · Journal of Clinical Medicine · doi:10.3390/jcm4081651 · Cited by 170
Gandhy, S. U., Kim, K., Larsen, L., Rosengren, R. J., & Safe, S. (2012) · BMC Cancer · doi:10.1186/1471-2407-12-564 · Cited by 164
Curcumin down-regulates AR gene expression and activation in prostate cancer cell lines
Nakamura, K., Yasunaga, Y., Segawa, T., Ko, D., Moul, J., Srivastava, S., & Rhim, J. (2002) · International Journal of Oncology · doi:10.3892/ijo.21.4.825 · Cited by 163
ZHAO, G., HAN, X., ZHENG, S., LI, Z., SHA, Y., NI, J., SUN, Z., QIAO, S., & SONG, Z. (2016) · Oncology Reports · doi:10.3892/or.2015.4413 · Cited by 163
Prasad, C. P., Rath, G., Mathur, S., Bhatnagar, D., & Ralhan, R. (2009) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2009.06.012 · Cited by 161
Zhang, J., Zhang, T., Ti, X., Shi, J., Wu, C., Ren, X., & Yin, H. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2010.07.013 · Cited by 158
Mukherjee, S., Mazumdar, M., Chakraborty, S., Manna, A., Saha, S., Khan, P., Bhattacharjee, P., Guha, D., Adhikary, A., Mukherjee, S., et al. (2014) · Stem Cell Research & Therapy · doi:10.1186/scrt506 · Cited by 155
Lev‐Ari, S., Starr, A., Vexler, A. M., Karaush, V., Loew, V., Greif, J., Fenig, E., Aderka, D., & Ben‐Yosef, R. (2006) · PubMed · Cited by 151
Expression of miR-34 is lost in colon cancer which can be re-expressed by a novel agent CDF
Roy, S., Levi, E., Majumdar, A. P. N., & Sarkar, F. H. (2012) · Journal of Hematology & Oncology · doi:10.1186/1756-8722-5-58 · Cited by 151
Mimeault, M., & Batra, S. K. (2011) · Chinese Medicine · doi:10.1186/1749-8546-6-31 · Cited by 144
Somers‐Edgar, T. J., Scandlyn, M. J., Stuart, E. C., Nedelec, M. J. L., Valentine, S. P., & Rosengren, R. J. (2007) · International Journal of Cancer · doi:10.1002/ijc.23328 · Cited by 141
Chen, B., Zhang, Y., Wang, Y., Rao, J., Jiang, X., & Xu, Z. (2014) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2014.01.009 · Cited by 140
The potential role of boswellic acids in cancer prevention and treatment
Roy, N. K., Deka, A., Bordoloi, D., Mishra, S., Kumar, A. P., Sethi, G., & Kunnumakkara, A. B. (2016) · Cancer Letters · doi:10.1016/j.canlet.2016.04.017 · Cited by 139
Self-citationLee, J., Lee, Y.-M., Chang, G., Yu, S., Hsieh, W.-Y., Chen, J. J. W., Chen, H., & Yang, P. (2011) · PLoS ONE · doi:10.1371/journal.pone.0023756 · Cited by 137
BELCARO, G. V., Hosoi, M., PELLEGRINI, L., Appendino, G., IPPOLITO, E., Ricci, A., Ledda, A. G., Dugall, M., Cesarone, M. R., Maione, C., et al. (2013) · Phytotherapy Research · doi:10.1002/ptr.5014 · Cited by 136
Choi, B. H., Kim, C. G., Bae, Y., Lim, Y., Lee, Y. H., & Shin, S. Y. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-5222 · Cited by 133
Kim, J. H., Xu, C., Keum, Y., Reddy, B. S., Conney, A. H., & Kong, A. T. (2005) · Carcinogenesis · doi:10.1093/carcin/bgi272 · Cited by 131
Du, Y., Long, Q., Zhang, L., SHI, Y., LIU, X., Li, X., GUAN, B., TIAN, Y., Wang, X., Li, L., et al. (2015) · International Journal of Oncology · doi:10.3892/ijo.2015.3202 · Cited by 128
Das, L., & Vinayak, M. (2015) · PLoS ONE · doi:10.1371/journal.pone.0124000 · Cited by 125
Curcumin: a novel Stat3 pathway inhibitor for chemoprevention of lung cancer
Alexandrow, M. G., Song, L., Altiok, S., Gray, J., Haura, E. B., & Kumar, N. B. (2011) · European Journal of Cancer Prevention · doi:10.1097/cej.0b013e32834ef194 · Cited by 125
Kim, S. G., Veena, M. S., Basak, S. K., Han, E., Tajima, T. L., Gjertson, D. W., Starr, J. M., Eidelman, O., Pollard, H. B., Srivastava, M., et al. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-1272 · Cited by 124
Pandey, A., Vishnoi, K., Mahata, S., Tripathi, S. C., Misra, S. P., Misra, V., Mehrotra, R., Dwivedi, M., & Bharti, A. C. (2015) · Nutrition and Cancer · doi:10.1080/01635581.2015.1085581 · Cited by 122
EGR-1, The Reluctant Suppression Factor:
Liu, C., Calogero, A., Ragona, G., Adamson, E. D., & Mercola, D. (1996) · Critical Reviews™ in Oncogenesis · doi:10.1615/critrevoncog.v7.i1-2.70 · Cited by 122
Liu, C., Calogero, A., Ragona, G., et al. (1996) · PubMed · Cited by 121
Curcumin attenuates EGF-induced AQP3 up-regulation and cell migration in human ovarian cancer cells
Ji, C., Cao, C., Lü, S., Kivlin, R., Amaral, A., KOUTTAB, N. M., Yang, H., Chu, W., Zhi-gang, B., Di, W. J., et al. (2008) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-007-0674-6 · Cited by 118
Multi-Targeted Agents in Cancer Cell Chemosensitization: What We Learnt from Curcumin Thus Far
Bordoloi, D., Roy, N. K., Monisha, J., et al. (2015) · Recent Patents on Anti-Cancer Drug Discovery · doi:10.2174/1574892810666151020101706 · Cited by 118
Self-citationNrf2 Knockout Attenuates the Anti-Inflammatory Effects of Phenethyl Isothiocyanate and Curcumin
Boyanapalli, S. S. S., Paredes‐Gonzalez, X., Fuentes, F., Zhang, C., Guo, Y., Pung, D., Saw, C. L. L., & Kong, A. T. (2014) · Chemical Research in Toxicology · doi:10.1021/tx500234h · Cited by 117
Jia, T., Zhang, L., Duan, Y., Zhang, M., Wang, G., Zhang, J., & Zhao, Z. (2014) · Cancer Cell International · doi:10.1186/s12935-014-0126-4 · Cited by 116
Fetoni, A. R., Paciello, F., Mezzogori, D., Rolesi, R., Eramo, S. L. M., Paludetti, G., & Troiani, D. (2015) · British Journal of Cancer · doi:10.1038/bjc.2015.359 · Cited by 116
Zhao, Z., Li, C., Xi, H., Gao, Y.-X., & Xu, D. (2015) · Molecular Medicine Reports · doi:10.3892/mmr.2015.4060 · Cited by 114
Irving, G. R. B., Howells, L. M., Sale, S., Kralj‐Hans, I., Atkin, W. S., Clark, S. K., Britton, R. G., Jones, D. J. L., Scott, E. N., Berry, D. P., et al. (2012) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-12-0281 · Cited by 113
Zamani, M., Sadeghizadeh, M., Behmanesh, M., & Najafi, F. (2015) · Phytomedicine · doi:10.1016/j.phymed.2015.05.071 · Cited by 111
Wu, L., Guo, L.-X., Liang, Y., Liu, X., Jiang, L., & Wang, L. (2015) · Oncology Reports · doi:10.3892/or.2015.4279 · Cited by 110
Ye, M.-X., Zhao, Y., Li, Y., Miao, Q., Li, Z., Ren, X., Song, L., Yin, H., & Zhang, J. (2012) · Phytomedicine · doi:10.1016/j.phymed.2012.03.005 · Cited by 109
Zhan, Y., Chen, Y., Liu, R., Zhang, H., & Zhang, Y. (2013) · Archives of Pharmacal Research · doi:10.1007/s12272-013-0311-3 · Cited by 107
Lai, C., Wu, J.-C., Yu, S., Badmaev, V., Nagabhushanam, K., Ho, C., & Pan, M. (2011) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201100290 · Cited by 105
Curcumin targets FOLFOX-surviving colon cancer cells via inhibition of EGFRs and IGF-1R.
Patel, B. B., Gupta, D., Elliott, A. A., Sengupta, V., Yu, Y., & Majumdar, A. P. N. (2010) · PubMed · Cited by 103
Kim, J.-M., Noh, E.-M., Kwon, K.-B., Kim, J., You, Y., Hwang, J.-K., Hwang, B.-M., Kim, B.-S., Lee, S.-H., Lee, S. J., et al. (2012) · Phytomedicine · doi:10.1016/j.phymed.2012.07.002 · Cited by 101
Chadalapaka, G., Jutooru, I., Burghardt, R. C., & Safe, S. H. (2010) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-09-0493 · Cited by 100
Qiao, Q., Jiang, Y., & Li, G. (2013) · Journal of Pharmacological Sciences · doi:10.1254/jphs.12149fp · Cited by 99
Potential of butein, a tetrahydroxychalcone to obliterate cancer
Padmavathi, G., Rathnakaram, S. R., Monisha, J., et al. (2015) · Phytomedicine · doi:10.1016/j.phymed.2015.08.015 · Cited by 98
Choi, H., Lim, J. E., & Hong, J. H. (2010) · Prostate Cancer and Prostatic Diseases · doi:10.1038/pcan.2010.26 · Cited by 98
Sundram, V., Chauhan, S. C., Ebeling, M. C., & Jaggi, M. (2012) · PLoS ONE · doi:10.1371/journal.pone.0035368 · Cited by 98
Oncogenic and tumor suppressive roles of microRNAs in apoptosis and autophagy
Chen, Y., Fu, L., Wen, X., Liu, B., Huang, J. M., Wang, J. ‐., & Wei, Y. (2014) · APOPTOSIS · doi:10.1007/s10495-014-0999-7 · Cited by 96
Gao, S.-M., Yang, J.-J., Chen, C.-Q., Chen, J.-J., Ye, L., Wang, L.-Y., Wu, J.-B., Xing, C., & Yu, K. (2012) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/1756-9966-31-27 · Cited by 94
EGFR Inhibition by Curcumin in Cancer Cells: A Dual Mode of Action
Starok, M., Preira, P., Vayssade, M., Haupt, K., Salomé, L., & Rossi, C. (2015) · Biomacromolecules · doi:10.1021/acs.biomac.5b00229 · Cited by 93
Plummer, S. M., Hill, K. A., Festing, M. F. W., et al. (2001) · PubMed · Cited by 92
Alizadeh, A. M., Khaniki, M., Azizian, S., Mohaghgheghi, M. A., Sadeghizadeh, M., & Najafi, F. (2012) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2012.06.016 · Cited by 91
Akkoç, Y., Berrak, Ö., Arısan, E. D., Yerlikaya, P. O., Gürkan, A. Ç., & Palavan-Ünsal, N. (2015) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2015.02.029 · Cited by 90
Cancer Stem Cells: A Novel Paradigm for Cancer Prevention and Treatment
Subramaniam, D. S., Ramalingam, S., Houchen, C. W., & Anant, S. (2010) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/138955710791330954 · Cited by 90
Yang, C.-W., Chang, C.-L., Lee, H., Chi, C., Pan, J., & Yang, W. (2012) · BMC Complementary and Alternative Medicine · doi:10.1186/1472-6882-12-22 · Cited by 89
Chapman‐Smith, A., Lutwyche, J. K., & Whitelaw, M. L. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m310041200 · Cited by 88
Functions of the Per/ARNT/Sim Domains of the Hypoxia-inducible Factor
Yang, J., Zhang, L., Erbel, P. J. A., Gardner, K. H., Ding, K., Garcia, J. A., & Bruick, R. K. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m501755200 · Cited by 87
Xu, Y., Zhang, J., Han, J., et al. (2012) · Molecular Oncology · doi:10.1016/j.molonc.2012.03.005 · Cited by 87
Lai, H., Chien, S., Kuo, S., Tseng, L., Lin, H., Chi, C., & Chen, D. (2011) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2012/486568 · Cited by 84
NF-κB-mediated miR-124 suppresses metastasis of non-small-cell lung cancer by targeting MYO10
Sun, Y., Ai, X., Shen, S., & Lü, S. (2015) · Oncotarget · doi:10.18632/oncotarget.3135 · Cited by 79
Lei, Z., Fan, D., Yi, X., Cao, X., Chen, D., & Wang, L. (2014) · PubMed Central · Cited by 76
Prevention and Treatment of Colorectal Cancer by Natural Agents from Mother Nature
Aggarwal, B. B., Prasad, S., Sung, B., Krishnan, S., & Guha, S. (2013) · Current Colorectal Cancer Reports · doi:10.1007/s11888-012-0154-1 · Cited by 75
Self-citationInhibitory effect of curcumin onMDR1 gene expression in patient leukemic cells
Anuchapreeda, S., Thanarattanakorn, P., Sittipreechacharn, S., Tima, S., Chanarat, P., & Limtrakul, P. (2006) · Archives of Pharmacal Research · doi:10.1007/bf02973907 · Cited by 73
Clark, C. A., McEachern, M. D., Shah, S. H., Rong, Y., Rong, X., Smelley, C. L., Caldito, G. C., Abreo, F. W., & Nathan, C. O. (2010) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-09-0244 · Cited by 73
Lu, Y., Wei, C., & Xi, Z. (2014) · In Vitro Cellular & Developmental Biology - Animal · doi:10.1007/s11626-014-9779-5 · Cited by 72
Basu, P. S., Dutta, S., Begum, R., Mittal, S., Dutta, P. D., Bharti, A. C., Panda, C. K., Biswas, J., Dey, B., Talwar, G. P., et al. (2013) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2013.14.10.5753 · Cited by 70
Wang, Q., Fan, H., Liu, Y., Yin, Z., Cai, H., Liu, J., Wang, Z., SHAO, M., Sun, X., Diao, J., et al. (2013) · International Journal of Oncology · doi:10.3892/ijo.2013.2237 · Cited by 70
NF-?B Blockers Gifted by Mother Nature: Prospectives in Cancer Cell Chemosensitization
Monisha, J., Padmavathi, G., Roy, N. K., et al. (2016) · Current Pharmaceutical Design · doi:10.2174/1381612822666160609110231 · Cited by 66
Roy, N. K., Bordoloi, D., Monisha, J., et al. (2016) · Current Drug Targets · doi:10.2174/1389450117666160307145236 · Cited by 65
Self-citationCurcumin: A potential radio‐enhancer in head and neck cancer
Khafif, A., Lev‐Ari, S., Vexler, A. M., Barnea, I., Starr, A., Karaush, V., Haif, S., & Ben‐Yosef, R. (2009) · The Laryngoscope · doi:10.1002/lary.20582 · Cited by 63
Kim, T., Fuchs, J. R., Schwartz, E. B., Abdelhamid, D. S., Etter, J. P., Berry, W. L., Li, C., Ihnat, M. A., Li, P., & Janknecht, R. (2014) · Europe PMC (PubMed Central) · Cited by 62
Curcumin inhibits hypoxia-induced angiogenesis via downregulation of HIF-1
Kim, S.-R., Bae, S., Kim, K., & Bae, M. (2006) · Vascular Pharmacology · doi:10.1016/j.vph.2006.08.403 · Cited by 60
Li, S., Liu, Z., Zhu, F., Fan, X., Wu, X., Zhao, H., & Jiang, L. (2014) · Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics · doi:10.3727/096504013x13832473330032 · Cited by 59
Banudevi, S., Sethuraman, S., & Krishnan, U. M. (2015) · ACS Combinatorial Science · doi:10.1021/acscombsci.5b00043 · Cited by 58
Mathur, A., Elmageed, Z. Y. A., Liu, X., Kostochka, M. L., Zhang, H., Abdel‐Mageed, A. B., & Mondal, D. (2014) · PLoS ONE · doi:10.1371/journal.pone.0103109 · Cited by 55
Modulation of curcumin-induced Akt phosphorylation and apoptosis by PI3K inhibitor in MCF-7 cells
Kizhakkayil, J., Thayyullathil, F., Chathoth, S., Hago, A., Patel, M. C., & Galadari, S. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2010.01.132 · Cited by 55
Tan, H. K., Moad, A. I. H., & Tan, M. L. (2014) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2014.15.16.6463 · Cited by 53
Catanionic lipid nanosystems improve pharmacokinetics and anti-lung cancer activity of curcumin
Li, S., Fang, C., Zhang, J., Liu, B., Wei, Z., Fan, X., Sui, Z., & Tan, Q. (2016) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2016.02.007 · Cited by 53
Antitumor and Antiangiogenic Activities of Curcumin in Cervical Cancer Xenografts in Nude Mice
Yoysungnoen, B., Bhattarakosol, P., & Patumraj, S. (2014) · BioMed Research International · doi:10.1155/2014/817972 · Cited by 52
Ledda, A., Belcaro, G. V., Dugall, M., Luzzi, R., Scoccianti, M., Togni, S., Appendino, G., & Ciammaichella, G. (2012) · PubMed · Cited by 51
Curcumin suppresses HIF1A synthesis and VEGFA release in pituitary adenomas
Shan, B., Schaaf, C. P., Schmidt, A., Lucia, K. E., Buchfelder, M., Losa, M., Kuhlen, D., Kreutzer, J., Perone, M. J., ARZT, E. S., et al. (2012) · Journal of Endocrinology · doi:10.1530/joe-12-0207 · Cited by 51
Yu, T., Li, J., Qiu, Y., & Sun, H. Y. (2011) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-011-1086-9 · Cited by 50
Rafiee, P., Binion, D. G., Wellner, M. R., Behmaram, B., Floer, M., Mitton‐Fitzgerald, E., Nie, L., Zhang, Z., & Otterson, M. F. (2010) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00339.2009 · Cited by 49
Wang, S., Lin, P.-Y., Chiu, Y.-C., Huang, J.-S., Kuo, Y.-T., Jen-Chine, W., & Chen, C. (2015) · PLoS ONE · doi:10.1371/journal.pone.0134110 · Cited by 48
Chen, J., Wang, F., & Chen, W. (2014) · Molecular Biology Reports · doi:10.1007/s11033-014-3329-9 · Cited by 48
PI3K/Akt pathway involving into apoptosis and invasion in human colon cancer cells LoVo
Jiang, Q., Li, T. Y., Liu, D. N., & Zhang, H.-T. (2014) · Molecular Biology Reports · doi:10.1007/s11033-014-3198-2 · Cited by 48
Guo, Y. C., Li, Y., Shan, Q., He, G., Lin, J., & Gong, Y. (2015) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2015.05.003 · Cited by 47
Das, L., & Vinayak, M. (2014) · International Immunopharmacology · doi:10.1016/j.intimp.2014.02.024 · Cited by 47
Curcumin Induces Cross-Regulation Between Autophagy and Apoptosis in Uterine Leiomyosarcoma Cells
Bin, L., Takeda, T., Tsuiji, K., Fang, W. T., Tadakawa, M., Akiko, K., Nagase, S., & Yaegashi, N. (2013) · International Journal of Gynecological Cancer · doi:10.1097/igc.0b013e31828c9581 · Cited by 47
Curcumin suppresses α-melanocyte stimulating hormone-stimulated melanogenesis in B16F10 cells
Choi (2010) · International Journal of Molecular Medicine · doi:10.3892/ijmm_00000440 · Cited by 46
Nuclear Factor Kappa B: A Potential Target to Persecute Head and Neck Cancer
Monisha, J., Roy, N. K., Bordoloi, D., et al. (2016) · Current Drug Targets · doi:10.2174/1389450117666160201112330 · Cited by 46
Self-citationWilms’ tumour gene 1 (WT1) as a target in curcumin treatment of pancreatic cancer cells
Glienke, W., Maute, L., Wicht, J., & Bergmann, L. (2009) · European Journal of Cancer · doi:10.1016/j.ejca.2008.12.030 · Cited by 45
Curcumin disrupts uterine leiomyosarcoma cells through AKT-mTOR pathway inhibition
Wong, T. F., Takeda, T., Li, B., Tsuiji, K., Kitamura, M., Kondo, A., & Yaegashi, N. (2011) · Gynecologic Oncology · doi:10.1016/j.ygyno.2011.03.001 · Cited by 45
Protective effect of curcumin against formaldehyde‐induced genotoxicity in A549 Cell Lines
Zhang, B., Shi, Y., Chen, X., Dai, J., Jiang, Z., Li, N., & Zhang, Z. (2012) · Journal of Applied Toxicology · doi:10.1002/jat.2814 · Cited by 43
Wang, S., Yu, S., Shi, W., Ge, L., Yu, X., Fan, J., & Zhang, J. (2011) · IUBMB Life · doi:10.1002/iub.507 · Cited by 43
Bhullar, K. S., Jha, A., & Rupasinghe, H. P. V. (2015) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2015.09.020 · Cited by 41
Wada, K., Lee, J.-Y., Hung, H., et al. (2015) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2015.02.003 · Cited by 41
Inhibitory effect of curcumin onWT1 gene expression in patient leukemic cells
Anuchapreeda, S., Limtrakul, P., Thanarattanakorn, P., Sittipreechacharn, S., & Chanarat, P. (2006) · Archives of Pharmacal Research · doi:10.1007/bf02977473 · Cited by 39
Lin, H., Kuo, L., & Chuu, C. (2011) · Phytotherapy Research · doi:10.1002/ptr.3523 · Cited by 37
Shan, X., Li, Y., Meng, X.-L., et al. (2014) · Food and Chemical Toxicology · doi:10.1016/j.fct.2014.01.046 · Cited by 37
Curcumin Inhibits STAT3 Signaling in the Colon of Dextran Sulfate Sodium-treated Mice
Yang, J.-Y., Zhong, X., Yum, H.-W., Lee, H.-J., Kundu, J. K., Na, H., & Surh, Y. (2013) · Journal of Cancer Prevention · doi:10.15430/jcp.2013.18.2.186 · Cited by 37
Lee, S.-S., Tsai, C., Yang, S., Ho, Y., & Chang, Y.-C. (2010) · Oral Diseases · doi:10.1111/j.1601-0825.2010.01680.x · Cited by 36
Inhibitory Effect of Curcumin on Invasion of Skin Squamous Cell Carcinoma A431 Cells
Wu, J., Lu, W., & Cui, L. (2015) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2015.16.7.2813 · Cited by 32
Li, Y., Wang, J., Li, X., Jia, Y., Huai, L., He, K., Yu, P., WANG, M., Xing, H., Rao, Q., et al. (2014) · Oncology Reports · doi:10.3892/or.2014.3529 · Cited by 30
Curcumin suppresses PPARδ expression and related genes in HT-29 cells
Wang, J., Qi, L., Zheng, S.-D., Wang, H.-Z., & Wu, T. (2009) · World Journal of Gastroenterology · doi:10.3748/wjg.15.1346 · Cited by 26
Comparative study of antioxidants as cancer preventives through inhibition of HIF-1 alpha activity
Upadhyay, J., Kesharwani, R. K., & Misra, K. (2009) · Bioinformation · doi:10.6026/97320630004233 · Cited by 21
(2001) · PubMed
(2001) · PubMed
Cited by
Curcumin: A Review of Its Effects on Human Health
Hewlings, S., & Kalman, D. (2017) · Foods · doi:10.3390/foods6100092 · Cited by 2,720
Loh, C.-Y., Chai, J., Tang, T., Wong, W., Sethi, G., Shanmugam, M., Chong, P., & Looi, C. (2019) · Cells · doi:10.3390/cells8101118 · Cited by 1,315
Phytochemicals in Cancer Treatment: From Preclinical Studies to Clinical Practice
Choudhari, A. S., Mandave, P. C., Deshpande, M., Ranjekar, P., & Prakash, O. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.01614 · Cited by 1,086
Innovative approaches for cancer treatment: current perspectives and new challenges
Pucci, C., Martinelli, C., & Ciofani, G. (2019) · ecancermedicalscience · doi:10.3332/ecancer.2019.961 · Cited by 814
Seca, A., & Pinto, D. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19010263 · Cited by 686
Metadata
- Authors
- Kunnumakkara, A. B., Bordoloi, D., Harsha, C., Banik, K., Gupta, S. C., & Aggarwal, B. B.
- Venue
- Clinical Science
- Publisher
- Portland Press Ltd.
- Published
- 2017-07-05
- Volume
- 131
- Issue
- 15
- Pages
- 1781-1799
- ISSN
- 0143-5221 (ISSN-L)
- 1470-8736
- OpenAlex
- W2724394355
- Cited by
- 332
- References
- 169
- FWCI
- 12.21
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.